TIL and Anti-PD1 in Metastatic Melanoma

Clinical trial NCT03638375 · UNKNOWN

Trial details

NCT number: NCT03638375
Sponsor: Leiden University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Toxicity, Drug Adverse Drug Event Effects of Immunotherapy

Start date: 2018-07-31
Primary completion: 2025-11-29
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.